Nukkleus INC. (DFNSW) — SEC Filings

Overview

Nukkleus INC. (DFNSW) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 30, 2025: On December 30, 2025, Nukkleus Inc. reported on several significant events. These include entering into a material definitive agreement, completing an acquisition or disposition of assets, creating a direct financial obligation, and unregistered sales of equity securities. The company also filed fin

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 6 bearish, 42 neutral, 2 mixed. The dominant filing sentiment for Nukkleus INC. is neutral.

Filing Type Overview

Nukkleus INC. (DFNSW) has filed 36 8-K, 1 DEFA14A, 2 DEF 14A, 3 10-Q, 3 S-1/A, 1 10-Q/A, 1 10-K/A, 1 S-1, 1 10-K, 1 SC 13G/A with the SEC between Oct 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (50)

• Nukkleus Inc. Files 8-K on Key Agreements and Acquisitions — 8-K · Dec 30, 2025 Risk: medium
  On December 30, 2025, Nukkleus Inc. reported on several significant events. These include entering into a material definitive agreement, completing an acquisiti
• Nukkleus Inc. Files 8-K — 8-K · Dec 17, 2025 Risk: low
  Nukkleus Inc. filed an 8-K on December 17, 2025, reporting other events and financial statements. The company, formerly known as Brilliant Acquisition Corp, is
• Nukkleus Inc. Files Definitive Additional Materials — DEFA14A · Dec 11, 2025 Risk: low
  Nukkleus Inc. filed a Definitive Additional Materials filing (DEFA14A) on December 11, 2025. This filing relates to proxy materials and indicates no fee was req
• Nukkleus Inc. Reports Director Changes and Officer Appointments — 8-K · Dec 9, 2025 Risk: medium
  Nukkleus Inc. filed an 8-K on December 9, 2025, reporting on the departure of directors, election of new directors, appointment of officers, and compensatory ar
• 8-K Filing — 8-K · Nov 28, 2025
• Nukkleus Inc. Files 8-K — 8-K · Nov 26, 2025 Risk: low
  Nukkleus Inc. filed an 8-K on November 26, 2025, reporting on other events and financial statements. The company, formerly known as Brilliant Acquisition Corp.
• 8-K Filing — 8-K · Nov 25, 2025
• Nukkleus Seeks Shareholder Nod for Star Acquisition, Major Dilution — DEF 14A · Nov 24, 2025 Risk: high
  Nukkleus Inc. (DFNSW) is seeking stockholder approval for four key proposals at a Special Meeting on December 16, 2025, primarily driven by Nasdaq Listing Rules
• Nukkleus Swings to Q3 Loss Amidst Divestiture, Warrant Revaluation Boosts YTD Income — 10-Q · Nov 14, 2025 Risk: high
  Nukkleus Inc. (DFNSW) reported a significant net income of $89,611,236 for the nine months ended September 30, 2025, a substantial increase from $409,575 in the
• 8-K Filing — 8-K · Nov 10, 2025
• Nukkleus Inc. Files 8-K with SEC — 8-K · Oct 17, 2025 Risk: low
  Nukkleus Inc. filed an 8-K on October 17, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Brill
• Nukkleus Seeks Shareholder Nod for New Equity Plan, Auditor — DEF 14A · Oct 16, 2025 Risk: high
  Nukkleus Inc. (DFNSW) is holding its 2025 Annual Meeting on November 6, 2025, virtually via webcast, to address several critical proposals. Stockholders will vo
• Nukkleus Inc. Files 8-K: Other Events & Financials — 8-K · Sep 29, 2025 Risk: low
  Nukkleus Inc. filed an 8-K on September 29, 2025, reporting an event that occurred on September 26, 2025. The filing pertains to 'Other Events' and 'Financial S
• Nukkleus Inc. Files 8-K: Material Agreements & Equity Sales — 8-K · Sep 19, 2025 Risk: medium
  Nukkleus Inc. filed an 8-K on September 19, 2025, reporting on a material definitive agreement, unregistered sales of equity securities, and other events. The f
• Nukkleus Inc. Files 8-K with Material Agreement — 8-K · Sep 16, 2025 Risk: medium
  Nukkleus Inc. filed an 8-K on September 16, 2025, reporting on events that occurred on September 15, 2025. The filing indicates a material definitive agreement
• Nukkleus Inc. Files 8-K with Material Agreements and Equity Sales — 8-K · Sep 5, 2025 Risk: medium
  Nukkleus Inc. filed an 8-K on September 5, 2025, reporting on several key events as of September 4, 2025. These include entering into a material definitive agre
• Nukkleus Inc. Files 8-K with Material Agreements — 8-K · Sep 2, 2025 Risk: medium
  Nukkleus Inc. filed an 8-K on September 2, 2025, reporting on events that occurred on September 1, 2025. The filing indicates a material definitive agreement an
• Nukkleus Inc. Files 8-K on Agreements and Equity Sales — 8-K · Aug 29, 2025 Risk: medium
  Nukkleus Inc. filed an 8-K on August 28, 2025, reporting on the entry into a material definitive agreement and unregistered sales of equity securities. The fili
• Nukkleus Inc. Files 8-K: Material Agreement & Other Events — 8-K · Aug 25, 2025 Risk: medium
  Nukkleus Inc. entered into a material definitive agreement on August 20, 2025. The filing also includes other events and financial statements and exhibits. The
• Nukkleus Swings to Profit on Warrant Revaluation, Pivots to Defense — 10-Q · Aug 14, 2025 Risk: high
  Nukkleus Inc. (DFNSW) reported a significant turnaround, posting a net income of $105,976,728 for the six months ended June 30, 2025, compared to a net loss of
• Nukkleus Inc. Files 8-K for Other Events — 8-K · Aug 8, 2025 Risk: low
  Nukkleus Inc. filed an 8-K on August 8, 2025, reporting an event on August 5, 2025. The filing is categorized under 'Other Events' and does not specify any mate
• Nukkleus Inc. Files 8-K: Material Agreement & Financials — 8-K · Jul 31, 2025 Risk: medium
  Nukkleus Inc. filed an 8-K on July 31, 2025, reporting a material definitive agreement and financial statements. The filing pertains to events on July 30, 2025,
• Nukkleus Amends S-1 for Continuous Public Offering — S-1/A · Jul 29, 2025 Risk: high
  Nukkleus Inc. filed Amendment No. 4 to its S-1 registration statement on July 29, 2025, under Registration No. 333-284880, indicating a proposed sale to the pub
• Nukkleus Inc. Files Material Definitive Agreement — 8-K · Jul 25, 2025 Risk: medium
  Nukkleus Inc. filed an 8-K on July 25, 2025, reporting a material definitive agreement. The filing also includes financial statements and exhibits. Nukkleus Inc
• Nukkleus Flags Non-Compliance with SEC Filing Requirements — 10-Q/A · Jul 9, 2025 Risk: high
  Nukkleus Inc. filed an Amendment No. 1 to its Form 10-Q for the quarterly period ended March 31, 2025. The filing indicates that Nukkleus Inc. is a non-accelera
• Nukkleus Inc. Files 8-K Under 'Other Events' — 8-K · Jun 30, 2025 Risk: medium
  Nukkleus Inc. filed an 8-K on June 30, 2025, reporting an event that occurred on June 25, 2025. The filing is categorized under 'Other Events' and does not prov
• Nukkleus Inc. Files 8-K for Material Agreement — 8-K · Jun 20, 2025 Risk: medium
  Nukkleus Inc. filed an 8-K on June 20, 2025, reporting a material definitive agreement entered into on June 15, 2025. The filing also includes financial stateme
• Nukkleus Amends S-1, Signals Continuous Offering Strategy — S-1/A · Jun 18, 2025 Risk: medium
  Nukkleus Inc. (DFNSW) filed an S-1/A on June 18, 2025, as an amendment to its registration statement, indicating a proposed continuous offering of securities un
• Nukkleus Reports Widening Losses, Zero Revenue in Q1 2025 — 10-Q · May 23, 2025 Risk: high
  Nukkleus Inc. (DFNSW) reported a net loss of $1.5 million for the three months ended March 31, 2025, a significant increase from the $0.5 million net loss in th
• Nukkleus Inc. Files S-1/A Amendment — S-1/A · May 15, 2025 Risk: medium
  Nukkleus Inc. filed an S-1/A amendment on May 15, 2025, for its registration statement. The company, formerly Brilliant Acquisition Corp., is incorporated in De
• Nukkleus Inc. Files 8-K for Material Agreement — 8-K · May 14, 2025 Risk: medium
  Nukkleus Inc. filed an 8-K on May 14, 2025, reporting the entry into a material definitive agreement. The filing also includes financial statements and exhibits
• Nukkleus Inc. Files 10-K/A Amendment — 10-K/A · Apr 14, 2025 Risk: low
  Nukkleus Inc. filed an amendment (Amendment No. 1) to its annual report on Form 10-K for the fiscal year ended September 30, 2024. The filing, submitted on Apri
• Nukkleus Inc. Amends Corporate Documents — 8-K · Feb 19, 2025 Risk: low
  Nukkleus Inc. filed an 8-K on February 19, 2025, reporting an amendment to its Articles of Incorporation or Bylaws, effective February 14, 2025. The company, pr
• Nukkleus Inc. Files Material Definitive Agreement 8-K — 8-K · Feb 14, 2025 Risk: medium
  Nukkleus Inc. filed an 8-K on February 14, 2025, reporting a material definitive agreement entered into on February 11, 2025. The filing also includes financial
• Nukkleus Inc. Files S-1 Registration Statement — S-1 · Feb 12, 2025 Risk: medium
  Nukkleus Inc. filed an S-1 registration statement with the SEC on February 12, 2025, detailing its intention to offer securities. The company, formerly known as
• Nukkleus Inc. Files 2024 Annual Report — 10-K · Feb 10, 2025 Risk: low
  Nukkleus Inc. filed its 10-K for the fiscal year ended September 30, 2024, reporting from its principal executive offices in New York, NY. The company, formerly
• Nukkleus Inc. Files 8-K — 8-K · Jan 16, 2025 Risk: low
  Nukkleus Inc. filed an 8-K on January 16, 2025, reporting other events and financial statements. The company, formerly known as Brilliant Acquisition Corp., is
• Nukkleus Inc. Financial Statements Not Reliable — 8-K · Jan 8, 2025 Risk: medium
  Nukkleus Inc. is filing an 8-K to report that its previously issued financial statements for the fiscal year ended December 31, 2024, should not be relied upon.
• Nukkleus Inc. Files 8-K for Material Agreement — 8-K · Jan 3, 2025 Risk: medium
  Nukkleus Inc. filed an 8-K on January 3, 2025, reporting a material definitive agreement entered into on December 27, 2024. The filing also includes financial s
• Nukkleus Inc. Files 8-K: Material Agreement & Equity Sales — 8-K · Dec 20, 2024 Risk: medium
  Nukkleus Inc. entered into a material definitive agreement on December 18, 2024, related to unregistered sales of equity securities. The filing also includes Re
• Nukkleus Inc. Files 8-K on Material Agreement — 8-K · Dec 17, 2024 Risk: low
  Nukkleus Inc. filed an 8-K on December 17, 2024, reporting on a material definitive agreement and financial statements. The filing date for the report is Decemb
• Nukkleus Inc. Files 8-K: Material Agreement & Equity Sales — 8-K · Dec 6, 2024 Risk: medium
  Nukkleus Inc. entered into a material definitive agreement on December 3, 2024, related to the creation of a direct financial obligation. The company also repor
• Nukkleus Inc. Files 8-K: Other Event Reported — 8-K · Nov 25, 2024 Risk: medium
  Nukkleus Inc. filed an 8-K on November 25, 2024, reporting an "Other Event." The filing does not contain specific details about the event, dollar amounts, or da
• Nukkleus Inc. Reports Unregistered Equity Sales — 8-K · Nov 22, 2024 Risk: medium
  Nukkleus Inc. filed an 8-K on November 22, 2024, reporting unregistered sales of equity securities on November 19, 2024. The filing also includes financial stat
• Nukkleus Inc. Faces Delisting Concerns, Reports Equity Sales — 8-K · Nov 15, 2024 Risk: high
  Nukkleus Inc. filed an 8-K on November 15, 2024, reporting events as of November 8, 2024. The filing indicates a notice of delisting or failure to meet continue
• Nukkleus Inc. Files 8-K with Material Agreements and Officer Changes — 8-K · Nov 12, 2024 Risk: medium
  Nukkleus Inc. filed an 8-K on November 12, 2024, reporting several key events. These include entering into a material definitive agreement, unregistered sales o
• SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Nukkleus Inc. Files 8-K with Financials and Exhibits — 8-K · Oct 22, 2024 Risk: low
  Nukkleus Inc. filed an 8-K on October 22, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Brill
• Nukkleus Inc. Files 8-K on Security Holder Rights & Bylaws — 8-K · Oct 18, 2024 Risk: medium
  Nukkleus Inc. filed an 8-K on October 18, 2024, reporting events as of October 11, 2024. The filing indicates material modifications to security holder rights,
• Nukkleus Inc. Files 8-K for Material Agreement — 8-K · Oct 4, 2024 Risk: medium
  Nukkleus Inc. filed an 8-K on October 4, 2024, reporting on a material definitive agreement entered into as of September 30, 2024. The filing also includes fina

Risk Profile

Risk Assessment: Of DFNSW's 46 recent filings, 8 were flagged as high-risk, 26 as medium-risk, and 12 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from Nukkleus INC.'s most recent 10-Q filing (Nov 14, 2025):

• Revenue: $0
• Net Income: $89.6M
• EPS: N/A
• Debt-to-Equity: N/A
• Cash Position: $7.6M
• Operating Margin: N/A
• Total Assets: $13.3M
• Total Debt: $43.7M

Key Executives

• Menachem Shalom
• Star Equity Holders
• Anastasiia Kotaieva
• Michael Wachs
• Stephen M. Fleming, Esq.

Industry Context

Nukkleus Inc. operates in a dynamic financial services sector, likely focusing on technology-driven solutions. The industry is characterized by rapid innovation, increasing regulatory scrutiny, and a constant need for capital to fuel growth and acquisitions. Companies often leverage strategic partnerships and equity financing to expand their market reach and service offerings.

Top Tags

material-agreement (17) · equity-sale (7) · 8-K (7) · filing (5) · corporate-governance (4) · corporate-action (4) · Emerging Growth Company (4) · 8-k (3) · filing-update (3) · financials (3)

Key Numbers

• Total consideration for Star acquisition: $21,000,000 — Comprises cash, promissory notes, and stock
• Shares of Common Stock issued to Star Equity Holders: 4,770,340 — Part of the Star acquisition consideration
• Shares exercisable via Star Warrant: 12,017,648 — Five-year warrant at $1.50 per share, part of Star acquisition
• Initial ownership of Star Equity Holders post-acquisition: 28.7% — Percentage of issued and outstanding Common Stock as of Record Date
• Potential ownership of Star Equity Holders post-warrant exercise: 100.9% — Percentage of issued and outstanding Common Stock as of Record Date, assuming Star Warrant exercise
• Shares exercisable via Warrants: 3,191,400 — At an exercise price of $5.405 per share for a five-year term
• Maximum commitment for Equity Line of Credit (ELOC): $250,000,000 — Potential sale of common shares to Esousa Group Holdings, LLC
• Aggregate purchase price for Series A Convertible Preferred Stock: $10,000,000 — Purchased by Esousa Group Holdings, LLC and another accredited investor
• Initial shares convertible from Series A Preferred Stock: 2,044,800 — Calculated at an initial conversion price of $4.89 per share
• Shares of Common Stock outstanding: 16,645,766 — As of the Record Date, November 17, 2025
• Net Income (YTD): $89.6M — Significant increase from $0.4M in 2024, primarily due to warrant revaluation.
• Total Revenues: $0 — No operational revenue reported for the three and nine months ended September 30, 2025.
• Net Loss (Q3 2025): $16.4M — A sharp decline from $4.5M net income in Q3 2024, indicating operational struggles.
• Change in fair value - stock purchase warrant liabilities: $123.4M — Primary driver of the year-to-date net income.
• Day one loss on private placement: $19.6M — Significant loss incurred in relation to a private placement.

Related Companies

NUKK · NUKKW

Frequently Asked Questions